Report Detail

Pharma & Healthcare Global and United States HER2 Antibody Market Insights, Forecast to 2026

  • RnM4174907
  • |
  • 31 August, 2020
  • |
  • Global
  • |
  • 131 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 HER2 Antibody Product Introduction
  • 1.2 Market Segments
  • 1.3 Key HER2 Antibody Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global HER2 Antibody Market Size Growth Rate by Type
    • 1.4.2 Trastuzumab
    • 1.4.3 Lapatinib
    • 1.4.4 Ado-trastuzumab Emtansine
    • 1.4.5 Pertuzumab
    • 1.4.6 Everolimus
  • 1.5 Market by Application
    • 1.5.1 Global HER2 Antibody Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Medical Center
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global HER2 Antibody Market Size, Estimates and Forecasts
    • 2.1.1 Global HER2 Antibody Revenue 2015-2026
    • 2.1.2 Global HER2 Antibody Sales 2015-2026
  • 2.2 Global HER2 Antibody, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 HER2 Antibody Historical Market Size by Region (2015-2020)
    • 2.3.1 Global HER2 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global HER2 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 HER2 Antibody Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global HER2 Antibody Sales Forecast by Region (2021-2026)
    • 2.4.2 Global HER2 Antibody Revenue Forecast by Region (2021-2026)

3 Global HER2 Antibody Competitor Landscape by Players

  • 3.1 Global Top HER2 Antibody Sales by Manufacturers
    • 3.1.1 Global HER2 Antibody Sales by Manufacturers (2015-2020)
    • 3.1.2 Global HER2 Antibody Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global HER2 Antibody Manufacturers by Revenue
    • 3.2.1 Global HER2 Antibody Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global HER2 Antibody Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global HER2 Antibody Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by HER2 Antibody Revenue in 2019
    • 3.2.5 Global HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global HER2 Antibody Price by Manufacturers
  • 3.4 Global HER2 Antibody Manufacturing Base Distribution, Product Types
    • 3.4.1 HER2 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers HER2 Antibody Product Type
    • 3.4.3 Date of International Manufacturers Enter into HER2 Antibody Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global HER2 Antibody Market Size by Type (2015-2020)
    • 4.1.1 Global HER2 Antibody Sales by Type (2015-2020)
    • 4.1.2 Global HER2 Antibody Revenue by Type (2015-2020)
    • 4.1.3 HER2 Antibody Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global HER2 Antibody Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global HER2 Antibody Sales Forecast by Type (2021-2026)
    • 4.2.2 Global HER2 Antibody Revenue Forecast by Type (2021-2026)
    • 4.2.3 HER2 Antibody Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global HER2 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global HER2 Antibody Market Size by Application (2015-2020)
    • 5.1.1 Global HER2 Antibody Sales by Application (2015-2020)
    • 5.1.2 Global HER2 Antibody Revenue by Application (2015-2020)
    • 5.1.3 HER2 Antibody Price by Application (2015-2020)
  • 5.2 HER2 Antibody Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global HER2 Antibody Sales Forecast by Application (2021-2026)
    • 5.2.2 Global HER2 Antibody Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global HER2 Antibody Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States HER2 Antibody Market Size YoY Growth 2015-2026
    • 6.1.1 United States HER2 Antibody Sales YoY Growth 2015-2026
    • 6.1.2 United States HER2 Antibody Revenue YoY Growth 2015-2026
    • 6.1.3 United States HER2 Antibody Market Share in Global Market 2015-2026
  • 6.2 United States HER2 Antibody Market Size by Players (International and Local Players)
    • 6.2.1 United States Top HER2 Antibody Players by Sales (2015-2020)
    • 6.2.2 United States Top HER2 Antibody Players by Revenue (2015-2020)
  • 6.3 United States HER2 Antibody Historic Market Review by Type (2015-2020)
    • 6.3.1 United States HER2 Antibody Sales Market Share by Type (2015-2020)
    • 6.3.2 United States HER2 Antibody Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States HER2 Antibody Price by Type (2015-2020)
  • 6.4 United States HER2 Antibody Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States HER2 Antibody Sales Forecast by Type (2021-2026)
    • 6.4.2 United States HER2 Antibody Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States HER2 Antibody Price Forecast by Type (2021-2026)
  • 6.5 United States HER2 Antibody Historic Market Review by Application (2015-2020)
    • 6.5.1 United States HER2 Antibody Sales Market Share by Application (2015-2020)
    • 6.5.2 United States HER2 Antibody Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States HER2 Antibody Price by Application (2015-2020)
  • 6.6 United States HER2 Antibody Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States HER2 Antibody Sales Forecast by Application (2021-2026)
    • 6.6.2 United States HER2 Antibody Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States HER2 Antibody Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America HER2 Antibody Market Size YoY Growth 2015-2026
  • 7.2 North America HER2 Antibody Market Facts & Figures by Country
    • 7.2.1 North America HER2 Antibody Sales by Country (2015-2020)
    • 7.2.2 North America HER2 Antibody Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe HER2 Antibody Market Size YoY Growth 2015-2026
  • 8.2 Europe HER2 Antibody Market Facts & Figures by Country
    • 8.2.1 Europe HER2 Antibody Sales by Country
    • 8.2.2 Europe HER2 Antibody Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific HER2 Antibody Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific HER2 Antibody Market Facts & Figures by Country
    • 9.2.1 Asia Pacific HER2 Antibody Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific HER2 Antibody Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America HER2 Antibody Market Size YoY Growth 2015-2026
  • 10.2 Latin America HER2 Antibody Market Facts & Figures by Country
    • 10.2.1 Latin America HER2 Antibody Sales by Country
    • 10.2.2 Latin America HER2 Antibody Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa HER2 Antibody Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa HER2 Antibody Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa HER2 Antibody Sales by Country
    • 11.2.2 Middle East and Africa HER2 Antibody Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Genentech Inc
    • 12.1.1 Genentech Inc Corporation Information
    • 12.1.2 Genentech Inc Description and Business Overview
    • 12.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Genentech Inc HER2 Antibody Products Offered
    • 12.1.5 Genentech Inc Recent Development
  • 12.2 Novartis AG
    • 12.2.1 Novartis AG Corporation Information
    • 12.2.2 Novartis AG Description and Business Overview
    • 12.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Novartis AG HER2 Antibody Products Offered
    • 12.2.5 Novartis AG Recent Development
  • 12.3 Pfizer
    • 12.3.1 Pfizer Corporation Information
    • 12.3.2 Pfizer Description and Business Overview
    • 12.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Pfizer HER2 Antibody Products Offered
    • 12.3.5 Pfizer Recent Development
  • 12.4 Abnova Corporation
    • 12.4.1 Abnova Corporation Corporation Information
    • 12.4.2 Abnova Corporation Description and Business Overview
    • 12.4.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Abnova Corporation HER2 Antibody Products Offered
    • 12.4.5 Abnova Corporation Recent Development
  • 12.5 InvivoGen
    • 12.5.1 InvivoGen Corporation Information
    • 12.5.2 InvivoGen Description and Business Overview
    • 12.5.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 InvivoGen HER2 Antibody Products Offered
    • 12.5.5 InvivoGen Recent Development
  • 12.6 Celltrion
    • 12.6.1 Celltrion Corporation Information
    • 12.6.2 Celltrion Description and Business Overview
    • 12.6.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Celltrion HER2 Antibody Products Offered
    • 12.6.5 Celltrion Recent Development
  • 12.7 Biocon Limited
    • 12.7.1 Biocon Limited Corporation Information
    • 12.7.2 Biocon Limited Description and Business Overview
    • 12.7.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Biocon Limited HER2 Antibody Products Offered
    • 12.7.5 Biocon Limited Recent Development
  • 12.8 Bio-Techne
    • 12.8.1 Bio-Techne Corporation Information
    • 12.8.2 Bio-Techne Description and Business Overview
    • 12.8.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Bio-Techne HER2 Antibody Products Offered
    • 12.8.5 Bio-Techne Recent Development
  • 12.11 Genentech Inc
    • 12.11.1 Genentech Inc Corporation Information
    • 12.11.2 Genentech Inc Description and Business Overview
    • 12.11.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Genentech Inc HER2 Antibody Products Offered
    • 12.11.5 Genentech Inc Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key HER2 Antibody Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 HER2 Antibody Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    HER2 Antibody market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global HER2 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the HER2 Antibody market is segmented into
    Trastuzumab
    Lapatinib
    Ado-trastuzumab Emtansine
    Pertuzumab
    Everolimus

    Segment by Application, the HER2 Antibody market is segmented into
    Hospital
    Medical Center

    Regional and Country-level Analysis
    The HER2 Antibody market is analysed and market size information is provided by regions (countries).
    The key regions covered in the HER2 Antibody market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and HER2 Antibody Market Share Analysis
    HER2 Antibody market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in HER2 Antibody business, the date to enter into the HER2 Antibody market, HER2 Antibody product introduction, recent developments, etc.
    The major vendors covered:
    Genentech Inc
    Novartis AG
    Pfizer
    Abnova Corporation
    InvivoGen
    Celltrion
    Biocon Limited
    Bio-Techne


    Summary:
    Get latest Market Research Reports on HER2 Antibody. Industry analysis & Market Report on HER2 Antibody is a syndicated market report, published as Global and United States HER2 Antibody Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of HER2 Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,984.13
    4,476.19
    5,968.26
    3,292.04
    4,938.06
    6,584.07
    408,423.60
    612,635.40
    816,847.20
    287,257.23
    430,885.85
    574,514.46
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report